Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Santiago Ortiz, Adrian J."" wg kryterium: Autor


Wyświetlanie 1-13 z 13
Tytuł :
Risk of serious infections in tocilizumab versus other biologic drugs in patients with rheumatoid arthritis: a multidatabase cohort study.
Autorzy :
Pawar, Ajinkya
Desai, Rishi J.
Solomon, Daniel H.
Ortiz, Adrian J. Santiago
Gale, Sara
Min Bao
Sarsour, Khaled
Schneeweiss, Sebastian
Kim, Seoyoung C.
Santiago Ortiz, Adrian J
Bao, Min
Pokaż więcej
Źródło :
Annals of the Rheumatic Diseases; Apr2019, Vol. 78 Issue 4, p456-464, 9p, 1 Diagram, 5 Charts
Czasopismo naukowe
Tytuł :
The EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) study programme: Design and exposure accrual for an evaluation of empagliflozin in routine clinical care.
Autorzy :
Patorno, Elisabetta
Najafzadeh, Mehdi
Pawar, Ajinkya
Franklin, Jessica M.
Déruaz‐Luyet, Anouk
Brodovicz, Kimberly G.
Santiago Ortiz, Adrian J.
Bessette, Lily G.
Kulldorff, Martin
Schneeweiss, Sebastian
Pokaż więcej
Źródło :
Endocrinology, Diabetes & Metabolism; Jan2020, Vol. 3 Issue 1, pN.PAG-N.PAG, 1p
Czasopismo naukowe
Tytuł :
Validation of claims-based algorithms for psoriatic arthritis.
Autorzy :
Lee H; Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.
Ford JA; Division of Rheumatology, Immunology and Allergy, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
Jin Y; Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.
Cho SK; Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.; Department of Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Seoul, Republic of Korea.
Santiago Ortiz AJ; Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.
Tong AY; Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.
Kim SC; Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.; Division of Rheumatology, Immunology and Allergy, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
Pokaż więcej
Źródło :
Pharmacoepidemiology and drug safety [Pharmacoepidemiol Drug Saf] 2020 Apr; Vol. 29 (4), pp. 404-408. Date of Electronic Publication: 2019 Dec 17.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
Czasopismo naukowe
Tytuł :
The EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) study programme: Design and exposure accrual for an evaluation of empagliflozin in routine clinical care.
Autorzy :
Patorno E; Division of Pharmacoepidemiology and Pharmacoeconomics Department of Medicine Brigham and Women's Hospital and Harvard Medical School Boston MA USA.
Najafzadeh M; Division of Pharmacoepidemiology and Pharmacoeconomics Department of Medicine Brigham and Women's Hospital and Harvard Medical School Boston MA USA.
Pawar A; Division of Pharmacoepidemiology and Pharmacoeconomics Department of Medicine Brigham and Women's Hospital and Harvard Medical School Boston MA USA.
Franklin JM; Division of Pharmacoepidemiology and Pharmacoeconomics Department of Medicine Brigham and Women's Hospital and Harvard Medical School Boston MA USA.
Déruaz-Luyet A; Boehringer Ingelheim GmbH Ingelheim Germany.
Brodovicz KG; Boehringer Ingelheim Pharmaceuticals, Inc. Ridgefield CT USA.
Santiago Ortiz AJ; Division of Pharmacoepidemiology and Pharmacoeconomics Department of Medicine Brigham and Women's Hospital and Harvard Medical School Boston MA USA.
Bessette LG; Division of Pharmacoepidemiology and Pharmacoeconomics Department of Medicine Brigham and Women's Hospital and Harvard Medical School Boston MA USA.
Kulldorff M; Division of Pharmacoepidemiology and Pharmacoeconomics Department of Medicine Brigham and Women's Hospital and Harvard Medical School Boston MA USA.
Schneeweiss S; Division of Pharmacoepidemiology and Pharmacoeconomics Department of Medicine Brigham and Women's Hospital and Harvard Medical School Boston MA USA.
Pokaż więcej
Źródło :
Endocrinology, diabetes & metabolism [Endocrinol Diabetes Metab] 2019 Nov 26; Vol. 3 (1), pp. e00103. Date of Electronic Publication: 2019 Nov 26 (Print Publication: 2020).
Typ publikacji :
Journal Article
Czasopismo naukowe
    Wyświetlanie 1-13 z 13

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies